Sympathomimetic amine / anti-obesity agent (DEA Schedule IV)Reviewed for 2026 plan year

Does UnitedHealthcare Cover Phentermine (Adipex-P / Lomaira)?

The verdict

Conditional on most plans

UnitedHealthcare (via OptumRx) covers phentermine only when the employer group has elected a weight-loss or anti-obesity-medication benefit. Plans with an AOM carve-out exclude it entirely, and standard Medicare Part D excludes it by statute. The defining OptumRx angle: some UHC plans require a documented trial of phentermine (or Contrave) as a step-therapy condition before approving a weight-loss GLP-1 such as Wegovy or Zepbound. For those readers, phentermine is not just an alternative — it may be the required first step. Phentermine is FDA-approved only for short-term use (~12 weeks) and is DEA Schedule IV. At $10–$40 for the generic, the step is cheap even paid out of pocket. UHC/OptumRx cells are representative composites; verify on OptumRx's drug lookup or UHC's member portal.

MedicareNot Covered
CommercialConditional
See the difference

Coverage is set by your specific plan and formulary. This is a research summary — always confirm with UnitedHealthcare using your member ID.

Reviewed for 2026
Checked against the active plan year
Sourced from formularies
UnitedHealthcare drug lists + CMS guidance
Updated as rules change
Coverage and prior-auth criteria shift often
Verify before you decide
Informational only — not insurance advice
  • Some UHC/OptumRx plans require a phentermine or Contrave trial as step-therapy before approving a weight-loss GLP-1 like Wegovy or Zepbound.

    OptumRx formulary and PA guidelines (composite)

  • Generic phentermine costs approximately $10–$40 per month cash — the least expensive FDA-approved weight-loss prescription in this cluster.

    GoodRx / SingleCare cash-price data, 2026

  • Only 19% of firms with 200+ workers covered GLP-1s primarily for weight loss in their largest plan (2025 KFF Employer Health Benefits Survey).

    KFF Employer Health Benefits Survey, Oct. 2025

Medicare vs. commercial coverage

Whether UnitedHealthcare covers Phentermine (Adipex-P / Lomaira) depends heavily on which kind of plan you hold. They follow completely different rules — here's each one, side by side.

Medicare

Part D & Advantage plans

Not Covered

Medicare Part D statutorily excludes phentermine as a weight-loss agent. This applies to all UnitedHealthcare Medicare Advantage (UnitedHealthcare Medicare Supplement) and Part D plans. Phentermine is NOT included in the 2026 Medicare GLP-1 Bridge (July 1, 2026 – December 31, 2027), which covers only specified injectable weight-loss GLP-1s — Wegovy formulations, Foundayo, and the Zepbound KwikPen. Medicare beneficiaries are ineligible for manufacturer copay cards under federal anti-kickback rules. Generic phentermine at $10–$40 cash is the operative route.

Commercial / Employer

Group & marketplace plans

Conditional

UHC commercial and employer plans (administered by OptumRx) cover phentermine only if the employer group has purchased an anti-obesity-medication benefit. Per the 2025 KFF Employer Health Benefits Survey, only 19% of firms with 200+ workers covered GLP-1s for weight loss — oral AOM coverage follows a similar pattern. Where covered, generic phentermine is typically a low-cost preferred AOM option on the OptumRx formulary. Step-therapy: some UHC/OptumRx plans require a documented trial of phentermine or Contrave before approving a weight-loss GLP-1 (Wegovy, Zepbound) — so phentermine may be the mandatory gateway for a patient trying to access a GLP-1. Prior authorization where applied: BMI of 30 or higher, or 27 or higher with a qualifying comorbidity; DEA Schedule IV quantity limits; short-term (~12 weeks) approvals. ACA marketplace plans (UHC Individual/Family) are frequently more restrictive and often exclude AOM. UHC Community Plan (Medicaid) coverage is state-dependent. All cells are representative composites; verify on OptumRx's drug lookup (optumrx.com) or the UHC member portal.

The 4 boxes you must tick to get approved

Commercial plans that will consider Phentermine (Adipex-P / Lomaira) require prior authorization. Check off what applies to you to see how close you are — this is a guide, not a guarantee of approval.

Requirements you meet0 / 4

0 of 4 requirements selected. Meet all 4 and you have a documented case for approval. Missing any one is the most common reason requests are denied.

Your cost, three ways

What Phentermine (Adipex-P / Lomaira) actually costs you swings enormously depending on how it's covered. Here's the realistic range.

No coverage

Paying cash

Generic phentermine: approximately $40 retail per month, as low as $10 with a discount coupon (GoodRx / SingleCare). Brand Adipex-P and Lomaira cost more; the generic is the near-universal fill.

List price with no coverage — before any manufacturer savings card.

PA approved

With coverage

Where phentermine is covered on a UHC commercial plan with an AOM benefit, generic tier co-pays are typically $0–$15 per month. Confirm your specific tier on the OptumRx member portal.

Typical monthly copay once prior authorization is approved.

No broad manufacturer copay card is available. The Adipex-P copay program was discontinued February 1, 2024. Third-party discount cards (GoodRx, SingleCare) reduce the generic to $10–$40 per month. Some states restrict coupons on DEA Schedule IV controlled substances. All figures are estimates; verify with your plan and pharmacy.

Check YOUR exact coverage in 3 steps

General answers only get you so far. Here's how to confirm your own plan's decision in a few minutes.

  1. 1

    Search OptumRx's drug lookup or UHC member portal to confirm AOM benefit

    Visit optumrx.com or the UnitedHealthcare member portal (myuhc.com) and search for phentermine with your member ID. If no coverage appears, your plan likely has an AOM carve-out. Also check whether your plan includes a step-therapy requirement before a weight-loss GLP-1 — this is key if your actual goal is Wegovy or Zepbound. Contact UHC member services (1-866-801-4409) if the portal is unclear.

  2. 2

    Confirm with your prescriber whether phentermine is a step toward a GLP-1

    If you are seeking a weight-loss GLP-1 (Wegovy, Zepbound) through UHC/OptumRx, ask your prescriber and OptumRx's PA team whether your plan requires a phentermine or Contrave trial first. At $10–$40 for the generic, completing the step is inexpensive. Document the trial carefully — prescriber notes, fill records, and any weight-loss progress — as this documentation supports the subsequent GLP-1 PA.

  3. 3

    Use the cash route if excluded — the generic is $10–$40

    If UHC excludes phentermine, the simplest path is cash with a discount coupon. Generic phentermine is typically $10–$40 per month with GoodRx or SingleCare at most retail pharmacies. No manufacturer program exists. Note that some states restrict coupons on Schedule IV controlled substances; verify in your state before presenting one.

Options if UnitedHealthcare won't cover Phentermine (Adipex-P / Lomaira)

A denial isn't the end of the road. These are the paths people commonly explore next — discuss any of them with your prescriber.

Wegovy / Zepbound (GLP-1 weight-loss agents) — phentermine may be the required step first

If your goal is a weight-loss GLP-1, be aware that some UHC/OptumRx plans require a phentermine or Contrave trial before approving Wegovy or Zepbound. At $10–$40 cash for the generic, that step is inexpensive. Verify step-therapy requirements before requesting a GLP-1 PA.

Contrave (naltrexone/bupropion) — CurAccess ~$99/month

Contrave is an oral anti-obesity combination drug. No generic exists; the Currax CurAccess cash program offers it at approximately $99 per month. Unlike phentermine, Contrave has no Schedule IV status and a longer label duration — though it carries a bupropion boxed warning for suicidality.

Qsymia generic (phentermine/topiramate ER) — launched 2025

A generic phentermine/topiramate ER entered the market in 2025 (Teva), approximately $63 with a coupon. It offers longer authorized use than standalone phentermine but requires a REMS program and has teratogenic risks.

These options are listed for information only — your own clinician decides what is appropriate for you.

Frequently Asked Questions

The Curex GLP-1 program

If UHC excludes phentermine or you prefer a longer-term weight-management path

You just saw how tangled Phentermine (Adipex-P / Lomaira) coverage can get — auto-rejections, prior authorization, and high cash prices. Curex compounded semaglutide: $199/month equivalent prepaid annually ($2,388 upfront), or $299/month paid monthly. Compounded tirzepatide: $299/month equivalent prepaid annually ($3,588 upfront), or $399/month paid monthly. Commercial rates as of 2026-10-12; compounded products are not FDA-approved and clinical eligibility must be assessed. Curex compounded medications are not the same as Phentermine (Adipex-P / Lomaira). No insurance or prior authorization required; prescription required, subject to provider review.

Compounded Semaglutide
$299/month
Monthly payment option
$2,388 upfront for one year — equivalent to $199/month
Compounded Tirzepatide
$399/month
Monthly payment option
$3,588 upfront for one year — equivalent to $299/month
  • Medication + free shipping
  • 24/7 provider access
  • Medical intake & prescription review
Monthly or annual paymentNo insurance requiredNo prior auth
Build your personalized planPrescription required, subject to provider review.

Compounded semaglutide and tirzepatide are not the same medications as Phentermine (Adipex-P / Lomaira) and are not branded or FDA-approved products. Compounded medications have not been approved by the FDA and the FDA has not evaluated their safety or efficacy.

This content is for informational purposes only and does not constitute medical, financial, or insurance advice. Coverage rules, prior-authorization criteria, and copay amounts change frequently and vary by plan, formulary tier, and effective date — always verify current benefits directly with UnitedHealthcare before making any decision. Consult a licensed healthcare provider and your plan administrator for guidance specific to your situation. Curex offers compounded semaglutide and tirzepatide, which are not the same medications as Phentermine (Adipex-P / Lomaira) and are not branded or FDA-approved products; prescription required, subject to provider review. Compounded medications have not been approved by the FDA and the FDA has not evaluated their safety or efficacy.

If UHC excludes phentermine or you prefer a longer-term weight-management path

Build your personalized plan

Compounded medications have not been approved by the FDA and the FDA has not evaluated their safety or efficacy.